Artiva Net Income vs Selling General Administrative Analysis

ARTV Stock   11.04  0.64  6.15%   
Artiva Biotherapeutics, financial indicator trend analysis is way more than just evaluating Artiva Biotherapeutics, prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Artiva Biotherapeutics, is a good investment. Please check the relationship between Artiva Biotherapeutics, Net Income and its Selling General Administrative accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artiva Biotherapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Net Income vs Selling General Administrative

Net Income vs Selling General Administrative Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Artiva Biotherapeutics, Net Income account and Selling General Administrative. At this time, the significance of the direction appears to have pay attention.
The correlation between Artiva Biotherapeutics,'s Net Income and Selling General Administrative is -0.79. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of Artiva Biotherapeutics, Common, assuming nothing else is changed. The correlation between historical values of Artiva Biotherapeutics,'s Net Income and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Artiva Biotherapeutics, Common are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Net Income i.e., Artiva Biotherapeutics,'s Net Income and Selling General Administrative go up and down completely randomly.

Correlation Coefficient

-0.79
Relationship DirectionNegative 
Relationship StrengthWeak

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Artiva Biotherapeutics, financial statement analysis. It represents the amount of money remaining after all of Artiva Biotherapeutics, Common operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Selling General Administrative

Most indicators from Artiva Biotherapeutics,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Artiva Biotherapeutics, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artiva Biotherapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Selling General Administrative is likely to climb to about 14.3 M in 2024, whereas Tax Provision is likely to drop slightly above 68.8 K in 2024.
 2021 2022 2023 2024 (projected)
Reconciled Depreciation248K1.2M2.3M2.4M
Total Operating Expenses55.3M64.8M64.2M55.7M

Artiva Biotherapeutics, fundamental ratios Correlations

0.15-0.92-0.38-0.87-0.830.6-0.430.60.62-0.96-0.51-0.85-0.950.15-0.8-0.38-0.6-0.5-0.810.6-0.43-0.950.7-0.95-0.37
0.15-0.46-0.53-0.49-0.380.77-0.540.740.69-0.32-0.56-0.02-0.40.83-0.57-0.53-0.46-0.64-0.560.77-0.56-0.410.73-0.41-0.57
-0.92-0.460.640.990.93-0.850.68-0.84-0.850.960.740.690.99-0.440.960.640.790.740.96-0.850.680.99-0.870.980.64
-0.38-0.530.640.740.75-0.881.0-0.9-0.890.440.99-0.110.52-0.660.811.00.930.920.81-0.881.00.52-0.610.470.99
-0.87-0.490.990.740.96-0.90.78-0.9-0.90.920.830.570.96-0.490.980.740.870.810.99-0.90.780.96-0.850.940.74
-0.83-0.380.930.750.96-0.830.78-0.83-0.80.890.820.490.9-0.310.910.750.930.720.92-0.830.760.9-0.690.860.72
0.60.77-0.85-0.88-0.9-0.83-0.911.00.98-0.69-0.93-0.24-0.770.77-0.95-0.88-0.88-0.94-0.941.0-0.91-0.780.89-0.75-0.9
-0.43-0.540.681.00.780.78-0.91-0.92-0.910.491.0-0.050.57-0.670.851.00.940.940.85-0.911.00.58-0.660.530.99
0.60.74-0.84-0.9-0.9-0.831.0-0.920.99-0.68-0.94-0.23-0.760.78-0.95-0.9-0.88-0.96-0.951.0-0.93-0.770.89-0.75-0.91
0.620.69-0.85-0.89-0.9-0.80.98-0.910.99-0.68-0.94-0.26-0.770.8-0.96-0.89-0.85-0.98-0.960.98-0.93-0.780.91-0.76-0.91
-0.96-0.320.960.440.920.89-0.690.49-0.68-0.680.560.820.99-0.220.850.440.670.540.86-0.690.480.99-0.760.980.42
-0.51-0.560.740.990.830.82-0.931.0-0.94-0.940.560.040.64-0.670.890.990.950.950.89-0.931.00.65-0.710.60.99
-0.85-0.020.69-0.110.570.49-0.24-0.05-0.23-0.260.820.040.790.060.48-0.110.140.110.49-0.24-0.040.78-0.540.81-0.1
-0.95-0.40.990.520.960.9-0.770.57-0.76-0.770.990.640.79-0.360.910.520.710.640.91-0.770.571.0-0.841.00.52
0.150.83-0.44-0.66-0.49-0.310.77-0.670.780.8-0.22-0.670.06-0.36-0.63-0.66-0.45-0.84-0.610.77-0.7-0.360.79-0.37-0.72
-0.8-0.570.960.810.980.91-0.950.85-0.95-0.960.850.890.480.91-0.630.810.870.91.0-0.950.850.91-0.910.90.82
-0.38-0.530.641.00.740.75-0.881.0-0.9-0.890.440.99-0.110.52-0.660.810.930.920.81-0.881.00.52-0.610.470.99
-0.6-0.460.790.930.870.93-0.880.94-0.88-0.850.670.950.140.71-0.450.870.930.820.88-0.880.920.71-0.610.660.9
-0.5-0.640.740.920.810.72-0.940.94-0.96-0.980.540.950.110.64-0.840.90.920.820.89-0.940.960.65-0.830.630.95
-0.81-0.560.960.810.990.92-0.940.85-0.95-0.960.860.890.490.91-0.611.00.810.880.89-0.940.850.92-0.90.90.82
0.60.77-0.85-0.88-0.9-0.831.0-0.911.00.98-0.69-0.93-0.24-0.770.77-0.95-0.88-0.88-0.94-0.94-0.91-0.780.89-0.75-0.9
-0.43-0.560.681.00.780.76-0.911.0-0.93-0.930.481.0-0.040.57-0.70.851.00.920.960.85-0.910.58-0.680.531.0
-0.95-0.410.990.520.960.9-0.780.58-0.77-0.780.990.650.781.0-0.360.910.520.710.650.92-0.780.58-0.851.00.52
0.70.73-0.87-0.61-0.85-0.690.89-0.660.890.91-0.76-0.71-0.54-0.840.79-0.91-0.61-0.61-0.83-0.90.89-0.68-0.85-0.86-0.65
-0.95-0.410.980.470.940.86-0.750.53-0.75-0.760.980.60.811.0-0.370.90.470.660.630.9-0.750.531.0-0.860.48
-0.37-0.570.640.990.740.72-0.90.99-0.91-0.910.420.99-0.10.52-0.720.820.990.90.950.82-0.91.00.52-0.650.48
Click cells to compare fundamentals

Artiva Biotherapeutics, Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Artiva Stock Analysis

When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.